眼科市場：疾患別、製品タイプ別、エンドユーザー別-2025-2030年の世界予測

眼科市場は、2023年に597億8,000万米ドルと評価され、2024年には637億2,000万米ドルに達すると予測され、CAGR 6.62％で成長し、2030年には936億9,000万米ドルに達すると予測されています。

眼科は、眼疾患の診断と治療を専門とする医学と外科学の一分野であり、技術の進歩と眼疾患の有病率の増加によって大きな変革が起きています。眼科の市場範囲には、緑内障、白内障、加齢黄斑変性、糖尿病性網膜症などの治療を目的とした手術機器、診断ツール、矯正レンズ、薬物療法が含まれます。革新的な眼科ソリューションの必要性は、世界人口の高齢化、糖尿病患者の増加、眼精疲労や視力問題の原因となるスクリーン使用時間の増加によって強調されています。眼科市場に影響を与える主な成長要因には、診断におけるAIや機械学習などの急速な技術革新、低侵襲手術技術の開拓、研究開発投資の急増などがあります。有望な機会は遠隔眼科にあり、遠隔地における眼科医療へのアクセスを強化し、診療ワークフローを最適化することができます。遺伝子治療と個別化医療も、視力に影響を及ぼす遺伝性疾患をターゲットにすることで変革の可能性を提示します。しかし、先進的な治療や機器に関連する高コスト、厳しい規制ガイドライン、熟練した専門家の不足といった限界に市場は直面しています。こうした課題には、費用対効果の高い機器開発や規制プロセスのナビゲーションといった適応戦略が必要です。技術革新と研究に最適な分野には、スマートコンタクトレンズ、AIを搭載した診断ツール、網膜スキャンの進歩が含まれ、眼疾患の早期発見と治療の改善が期待されます。市場情勢の特徴は競合情勢にあり、新たな動向や患者のニーズに対応するための継続的な技術革新と適応が求められます。このような機会を活用するために、企業は研究開発に投資し、技術的進歩のためのパートナーシップを優先させ、世界的にコスト問題に対処し眼科医療サービスへのアクセスを改善しながら、ケア提供を強化する患者中心のソリューションに焦点を当てるべきです。

市場力学：急速に進化する眼科市場の主要市場インサイトを公開

眼科市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 眼障害の有病率と国民の意識の高まり
  • 処方眼鏡と処方レンズの採用の増加
  • 設備の整ったヘルスケア・インフラの存在と医薬品承認の増加
• 市場抑制要因
  • 眼科治療費の高騰
• 市場機会
  • 眼科治療の新たな調査活動と助成金の利用可能性
  • 眼科の技術統合による高い利用可能性
• 市場の課題
  • 眼科治療の熟練した専門家の不足

ポーターの5つの力：眼科市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：眼科市場における外部からの影響の把握

外部マクロ環境要因は、眼科市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析眼科市場における競合情勢の把握

眼科市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス眼科市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、眼科市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨眼科市場における成功への道筋を描く

眼科市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 眼疾患の蔓延と国民の意識の高まり
    • 処方眼鏡やレンズの採用増加
    • 設備の整ったヘルスケアインフラの存在と医薬品の承認数の増加
  • 抑制要因
    • 眼科治療の高額な費用
  • 機会
    • 眼科治療に関する新たな調査活動と助成金の利用可能性
    • 眼科の技術統合により、高い利用可能性が期待できます
  • 課題
    • 眼科手術の熟練した専門家が限られている
• 市場セグメンテーション分析
  • 疾患：人口のかなりの割合で、近視、遠視、乱視、老眼などの屈折異常がみられます。
  • 製品タイプ：眼科におけるソフトウェア開発への投資の増加
  • エンドユーザー：世界中の医療機関による継続的な調査活動
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 眼科市場病気別

• 加齢黄斑変性症
• 白内障
• 緑内障
• 炎症性疾患
• 屈折異常

第7章 眼科市場：製品タイプ別

• 薬物
  • アレルギー性結膜炎および炎症治療薬
  • ドライアイ薬
  • 緑内障薬
  • 網膜疾患治療薬
• 装置
  • 診断装置
  • 外科用機器
    • 眼内レンズ
    • 眼科用レーザー
• 処方眼鏡とレンズ
• ソフトウェア

第8章 眼科市場：エンドユーザー別

• ヘルスケアサービスプロバイダー
• 病院
• 医療機関
• 調査機関

第9章 南北アメリカの眼科市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の眼科市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの眼科市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ビーコン・セラピューティクス、眼科遺伝子治療の推進と世界展開のためシリーズB資金調達で1億7,000万米ドルを確保
  • テアファーマ株式会社はラタノプロスト点眼液の患者をサポートする新しいリソースを導入しました
  • BioPhtaは、革新的な眼疾患治療を臨床試験に進め、世界規模で展開するために650万ユーロを調達しました。
  • ClarioとEmSereが戦略的提携を結び、高度な画像化とデータ統合により眼科臨床試験に革命を起こす
  • バイオコン・バイオロジクス・リミテッドはバイオシミラーのアフリベルセプトの米国FDA承認を取得し、米国に進出眼科市場
  • トプコンとマイクロソフトが協力し、AIを活用したヘルスケアプラットフォームで眼科診断に革命を起こす
  • Eye2Gene LimitedとHeidelberg Engineering, Inc.のコラボレーションがARVOで発表されました2024
  • Nordic Pharma, Inc.がASCRS年次総会でLACRIFILLの発売に向けて準備中
  • Clarioとクリーブランドクリニック財団のCole Eye Instituteは、臨床試験を強化するための戦略的パートナーシップを結びました。
  • Refocus Eye Healthはニュージャージー州の8つの一流医療機関と提携し、専門的な眼科サービスを強化しています。
  • イケリアンAG、眼科データ分析を強化するための発見コアプラットフォームを発表
  • CiplaはCSIR-CDRIと提携して眼科用抗真菌治療の革新を図り、研究開発と世界市場への進出を加速します。
• 戦略分析と提言
  • アルコン株式会社
  • エシロールルックスオティカS.A.
  • アッヴィ株式会社
  • ボシュロム・コーポレーション

企業一覧

• AbbVie Inc.
• Alcon Inc.
• Alkeus Pharmaceuticals, Inc.
• Apotex Inc.
• Bausch+Lomb Corporation
• C.H. Boehringer Sohn AG & Co. KG
• Carl Zeiss AG
• ClearSight LLC
• CooperVision, Inc.
• Duopharma Biotech Berhad
• Essex Bio-Technology Limited
• EssilorLuxottica S.A.
• Eyenovia, Inc.
• F. Hoffmann-La Roche AG
• GenSight Biologics S.A.
• Geri-Care Pharmaceuticals Corp.
• Glaukos Corporation
• Halma PLC
• Harrow Health, Inc.
• Honeywell International Inc.
• Hoya Corporation
• Johnson & Johnson Services Inc.
• Kubota Pharmaceutical Holdings Co., Ltd.
• Lumenis Be Ltd.
• Nidek Co., Ltd.
• Novartis AG
• OCuSOFT, Inc.
• Oxurion NV
• Pfizer, Inc.
• Santen Pharmaceutical Co., Ltd.
• SEED Co., Ltd.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
• Topcon Corporation
• Unimed Pharma, Spols r.o.
• Visioncare Optolab Pvt. Ltd.

LIST OF FIGURES

• FIGURE 1. OPHTHALMOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. OPHTHALMOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OPHTHALMOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 54. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 57. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 86. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 88. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 89. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 90. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 92. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 94. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 95. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 96. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. ITALY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 195. ITALY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. ITALY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 197. ITALY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 198. ITALY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. ITALY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. POLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 219. POLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 220. POLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 221. POLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 222. POLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. POLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. QATAR OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 225. QATAR OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. QATAR OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 227. QATAR OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 228. QATAR OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. QATAR OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 285. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Ophthalmology Market was valued at USD 59.78 billion in 2023, expected to reach USD 63.72 billion in 2024, and is projected to grow at a CAGR of 6.62%, to USD 93.69 billion by 2030.

Ophthalmology, the branch of medicine and surgery dedicated to the diagnosis and treatment of eye disorders, is witnessing a significant transformation driven by technological advancements and increasing prevalence of eye diseases. The market scope for ophthalmology encompasses surgical devices, diagnostic tools, corrective lenses, and medication aimed at treating conditions like glaucoma, cataracts, age-related macular degeneration, and diabetic retinopathy. The necessity for innovative ophthalmological solutions is underscored by the aging global population, rising diabetes cases, and increased screen time, contributing to eye strain and vision problems. end-use segments primarily include hospitals, ambulatory surgical centers, and specialized eye clinics. Key growth factors influencing the ophthalmology market include rapid technological innovations such as AI and machine learning in diagnostics, development of minimally invasive surgical techniques, and an upsurge in R&D investments. A promising opportunity lies in tele-ophthalmology, which can enhance access to eye care in remote areas and optimize practice workflows. Gene therapy and personalized medicine also present transformative potential by targeting genetic disorders affecting vision. However, the market faces limitations like high costs associated with advanced treatments and devices, stringent regulatory guidelines, and a shortage of skilled professionals. These challenges necessitate adaptive strategies, such as cost-effective device development and regulatory process navigation. The best areas for innovation and research involve smart contact lenses, AI-powered diagnostic tools, and advancements in retinal scans, which promise improved early detection and treatment of eye conditions. The ophthalmology market's nature is characterized by its competitive landscape, which demands continuous innovation and adaptation to meet emerging trends and patient needs. To leverage these opportunities, businesses should invest in R&D, prioritize partnerships for technological advancement, and focus on patient-centric solutions that enhance care delivery while addressing cost concerns and improving access to eye care services globally.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmology Market

The Ophthalmology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of eye disorders and growing awareness among the population
  • Increasing adoption of prescription glasses and lenses
  • Presence of well-equipped healthcare infrastructure and an increasing number of drug approvals
• Market Restraints
  • High cost of ophthalmologic treatments
• Market Opportunities
  • Emerging research activities of ophthalmology treatments and availability of grants
  • High usage potential owing to the technological integrations in Ophthalmology
• Market Challenges
  • Limited skilled professionals for ophthalmic procedures

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmology Market

A detailed market share analysis in the Ophthalmology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmology Market

A strategic analysis of the Ophthalmology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch + Lomb Corporation, C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, CooperVision, Inc., Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd., Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Topcon Corporation, Unimed Pharma, Spols r.o., and Visioncare Optolab Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Ophthalmology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Diseases, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.
• Based on Product Type, market is studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers.
• Based on End User, market is studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of eye disorders and growing awareness among the population
    • 5.1.1.2. Increasing adoption of prescription glasses and lenses
    • 5.1.1.3. Presence of well-equipped healthcare infrastructure and an increasing number of drug approvals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of ophthalmologic treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
    • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
  • 5.1.4. Challenges
    • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
• 5.2. Market Segmentation Analysis
  • 5.2.1. Diseases: Prevalence of refractive errors such as myopia, hyperopia, astigmatism, and presbyopia in a significant portion of the population
  • 5.2.2. Product Type: Increasing investments in software development in ophthalmology
  • 5.2.3. End User: Continuous research activities by medical institutes worldwide
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Ophthalmology Market, by Diseases

• 6.1. Introduction
• 6.2. Age-Related Macular Degeneration
• 6.3. Cataract
• 6.4. Glaucoma
• 6.5. Inflammatory Diseases
• 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

• 7.1. Introduction
• 7.2. Drugs
  • 7.2.1. Allergic Conjunctivitis & Inflammation Drugs
  • 7.2.2. Dry Eye Drugs
  • 7.2.3. Glaucoma Drugs
  • 7.2.4. Retinal Disorder Drugs
• 7.3. Equipment
  • 7.3.1. Diagnostic Devices
  • 7.3.2. Surgical Devices
    • 7.3.2.1. Intraocular Lenses
    • 7.3.2.2. Ophthalmic Lasers
• 7.4. Prescription Glasses & Lens
• 7.5. Software

8. Ophthalmology Market, by End User

• 8.1. Introduction
• 8.2. Healthcare Service Providers
• 8.3. Hospitals
• 8.4. Medical Institutes
• 8.5. Research Organizations

9. Americas Ophthalmology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Ophthalmology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Beacon Therapeutics secures USD 170 Million in series B funding to propel ophthalmic gene therapies and drive global expansion
  • 12.3.2. Thea Pharma Inc. introduced new resources to support latanoprost ophthalmic solution patients
  • 12.3.3. BioPhta raises EUR 6.5 million to propel innovative eye disease treatments to clinical trials and expand global reach
  • 12.3.4. Clario and EmSere forge strategic partnership to revolutionize ophthalmic clinical trials with advanced imaging and data integration
  • 12.3.5. Biocon Biologics Limited received U.S. FDA approval for biosimilar aflibercept, enters U.S. ophthalmology market
  • 12.3.6. Topcon and Microsoft join forces to revolutionize ophthalmic diagnostics with AI-powered healthcare platform
  • 12.3.7. A collaboration between Eye2Gene Limited and Heidelberg Engineering, Inc. was announced at ARVO 2024
  • 12.3.8. Nordic Pharma, Inc. gears up for LACRIFILL launch at ASCRS annual meeting
  • 12.3.9. Clario and Cleveland Clinic Foundation's Cole Eye Institute formed a strategic partnership for enhanced ophthalmology clinical trials
  • 12.3.10. Refocus Eye Health is partnering with eight premier practices in New Jersey to enhance specialized eye services
  • 12.3.11. Ikerian AG unveiled a discovery core platform for enhanced ophthalmic data analysis
  • 12.3.12. Cipla joins forces with CSIR-CDRI to innovate ophthalmic antifungal treatments, accelerating R&D and global market reach
• 12.4. Strategy Analysis & Recommendation
  • 12.4.1. Alcon Inc.
  • 12.4.2. EssilorLuxottica S.A.
  • 12.4.3. AbbVie Inc.
  • 12.4.4. Bausch + Lomb Corporation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Alcon Inc.
• 3. Alkeus Pharmaceuticals, Inc.
• 4. Apotex Inc.
• 5. Bausch + Lomb Corporation
• 6. C.H. Boehringer Sohn AG & Co. KG
• 7. Carl Zeiss AG
• 8. ClearSight LLC
• 9. CooperVision, Inc.
• 10. Duopharma Biotech Berhad
• 11. Essex Bio-Technology Limited
• 12. EssilorLuxottica S.A.
• 13. Eyenovia, Inc.
• 14. F. Hoffmann-La Roche AG
• 15. GenSight Biologics S.A.
• 16. Geri-Care Pharmaceuticals Corp.
• 17. Glaukos Corporation
• 18. Halma PLC
• 19. Harrow Health, Inc.
• 20. Honeywell International Inc.
• 21. Hoya Corporation
• 22. Johnson & Johnson Services Inc.
• 23. Kubota Pharmaceutical Holdings Co., Ltd.
• 24. Lumenis Be Ltd.
• 25. Nidek Co., Ltd.
• 26. Novartis AG
• 27. OCuSOFT, Inc.
• 28. Oxurion NV
• 29. Pfizer, Inc.
• 30. Santen Pharmaceutical Co., Ltd.
• 31. SEED Co., Ltd.
• 32. Sun Pharmaceutical Industries Limited
• 33. Teva Pharmaceutical Industries Ltd.
• 34. Topcon Corporation
• 35. Unimed Pharma, Spols r.o.
• 36. Visioncare Optolab Pvt. Ltd.